184 related articles for article (PubMed ID: 14696464)
1. Hepatocellular carcinoma presenting with obstructive jaundice: a clinicopathological study of eight cases.
Murata K; Shiraki K; Kawakita T; Yamamoto N; Okano H; Sakai T; Ohmori S; Deguchi M; Shimizu A; Nakano T
Hepatogastroenterology; 2003; 50(54):2057-60. PubMed ID: 14696464
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma presenting with obstructive jaundice.
Lai EC; Lau WY
ANZ J Surg; 2006 Jul; 76(7):631-6. PubMed ID: 16813631
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma with tumor thrombi in the bile duct.
Wang HJ; Kim JH; Kim JH; Kim WH; Kim MW
Hepatogastroenterology; 1999; 46(28):2495-9. PubMed ID: 10522026
[TBL] [Abstract][Full Text] [Related]
4. Successful diagnosis and resection of icteric type hepatocellular carcinoma.
Murakami Y; Yokoyama T; Kanehiro T; Uemura K; Sasaki M; Morifuji M; Sueda T
Hepatogastroenterology; 2003; 50(53):1634-6. PubMed ID: 14571803
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
[TBL] [Abstract][Full Text] [Related]
6. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein.
Shuqun C; Mengchao W; Han C; Feng S; Jiahe Y; Guanghui D; Wenming C; Peijun W; Yuxiang Z
Hepatogastroenterology; 2007 Mar; 54(74):499-502. PubMed ID: 17523307
[TBL] [Abstract][Full Text] [Related]
7. [Obstructive jaundice caused by hepatocellular carcinoma].
Nardello O; Farina GP; Cagetti M
Ann Ital Chir; 2005; 76(6):535-41. PubMed ID: 16821515
[TBL] [Abstract][Full Text] [Related]
8. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
[TBL] [Abstract][Full Text] [Related]
9. Are endoscopic or percutaneous biliary drainage effective for obstructive jaundice caused by hepatocellular carcinoma?
Cho HC; Lee JK; Lee KH; Lee KT; Paik S; Choo SW; Do YS; Choo IW
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):224-31. PubMed ID: 21228705
[TBL] [Abstract][Full Text] [Related]
10. Capsular formation surrounding hepatocellular carcinoma.
Iwamura K
Tokai J Exp Clin Med; 1986 Aug; 11(3):185-99. PubMed ID: 3039694
[TBL] [Abstract][Full Text] [Related]
11. Unusual presentation of recurrent hepatocellular carcinoma as obstructive jaundice 15 years after liver transplant.
Camci C; Gurakar A; Kohli V; Sharma S; Jabbour N
Exp Clin Transplant; 2007 Dec; 5(2):713-5. PubMed ID: 18194129
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases.
Zhou J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ; Fan J
Hepatogastroenterology; 2006; 53(68):275-80. PubMed ID: 16608039
[TBL] [Abstract][Full Text] [Related]
13. Extra-hepatic hepatocellular carcinoma presenting as obstructive jaundice.
Batsis JA; Halfdanarson TR; Pitot H
Dig Liver Dis; 2006 Oct; 38(10):768-71. PubMed ID: 16243009
[TBL] [Abstract][Full Text] [Related]
14. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.
Hata M; Tokuuye K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Ohara K; Matsuzaki Y; Tanaka N; Akine Y
Cancer; 2005 Aug; 104(4):794-801. PubMed ID: 15981284
[TBL] [Abstract][Full Text] [Related]
15. Hepatic resection for icteric type hepatocellular carcinoma.
Shimada M; Takenaka K; Hasegawa H; Shirabe K; Gion T; Kano T; Sugimachi K
Hepatogastroenterology; 1997; 44(17):1432-7. PubMed ID: 9356868
[TBL] [Abstract][Full Text] [Related]
16. Dynamic MR studies of hepatocellular carcinoma with portal vein tumor thrombosis.
Mitani T; Nakamura H; Murakami T; Nishikawa M; Maeshima S; Nakanishi K; Marukawa T; Harada K; Hori S; Kozuka T
Radiat Med; 1992; 10(6):232-4. PubMed ID: 1337618
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma].
Kim YI; Ki HS; Kim MH; Cho DK; Cho SB; Joo YE; Kim HS; Choi SK; Rew JS
Korean J Hepatol; 2009 Jun; 15(2):148-58. PubMed ID: 19581767
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
Hiraoka A; Horiike N; Yamashita Y; Koizumi Y; Doi H; Yamamoto Y; Ichikawa S; Hasebe A; Yano M; Miyamoto Y; Ninomiya T; Ootani H; Takamura K; Kawasaki H; Otomi Y; Kogame M; Sogabe I; Ishimaru Y; Kashihara K; Miyagawa M; Hirooka M; Hiasa Y; Matsuura B; Michitaka K; Onji M
Hepatogastroenterology; 2009; 56(89):213-7. PubMed ID: 19453060
[TBL] [Abstract][Full Text] [Related]
20. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.
Chen XP; Qiu FZ; Wu ZD; Zhang ZW; Huang ZY; Chen YF; Zhang BX; He SQ; Zhang WG
Ann Surg Oncol; 2006 Jul; 13(7):940-6. PubMed ID: 16788755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
